![Italian Medicines Agency](https://www.aifa.gov.it/o/aifa-theme/images/aifa/AIFA2021_Col(LR).png)
Direct communication with healthcare professionals on Tresiba - Direct communication with healthcare professionals on Tresiba
Direct communication with healthcare professionals on Tresiba
Tresiba® FlexTouch® 100 U/ML 5 pre-filled pens (A.I.C. 042658029) is in shortage (discontinous supplies) due to a reduced production capacity of the holder.
At the moment, a period of discontinuous supplies from 11 July until 20 August 2023 is confirmed, but it is estimated that the supply of Tresiba® FlexTouch® 100 U/ML 5 pre-filled pens (A.I.C. 042658029), could be intermittent for the entire year 2023. The shortage of supply is not related to any defect in the quality of the medicine or safety concerns and has been notified to the Competent Authority.
Professional healthcares are urged to ensure that patients using Tresiba® FlexTouch® 100 U/ML 5 pre-filled pens (A.I.C. 042658029) are made aware of this issue and to prescribe to each patient the number of packs of Tresiba® FlexTouch® 100 U/ML strictly necessary for the continuation of therapy, to avoid hoarding phenomena and thus guarantee all patients access to therapy.
Published on: 01 August 2023